Bluejay Diagnostics (BJDX) Return on Capital Employed (2021 - 2026)
Bluejay Diagnostics recorded quarterly Return on Capital Employed of 141.62% in Q1 2026, little changed quarter-over-quarter from 142.32% in Q4 2025, and up 94.0% year-over-year from 73.0% in Q1 2025.
Bluejay Diagnostics' Return on Capital Employed history runs 6 years deep, the most recent figure standing at 141.62% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 94.0% year-over-year to 141.62%; the TTM figure through Mar 2026 stood at 141.62% (up 94.0% YoY), while the FY2025 annual figure was 120.52%, up 2424.0% from the prior year.
- Return on Capital Employed came in at 141.62% for Q1 2026 at Bluejay Diagnostics, roughly flat from 142.32% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 26.33% in Q1 2022 to a low of 291.92% in Q1 2024.
- A 5-year average of 128.64% and a median of 140.02% in 2025 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed plunged 19985 bps in 2024 and jumped 14936 bps in 2025, its largest moves.
- Bluejay Diagnostics' Return on Capital Employed stood at 71.82% in 2022, then slumped by 200 bps to 215.44% in 2023, then surged by 50 bps to 107.09% in 2024, then slumped by 33 bps to 142.32% in 2025, then grew by 0 bps to 141.62% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 141.62%, 142.32%, and 155.09% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - | -141.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -141.62% |
| Dec 31, 2025 | -142.32% |
| Sep 30, 2025 | -155.09% |
| Jun 30, 2025 | -140.02% |
| Mar 31, 2025 | -142.56% |
| Dec 31, 2024 | -107.09% |
| Sep 30, 2024 | -93.79% |
| Jun 30, 2024 | -153.15% |
| Mar 31, 2024 | -291.92% |
| Dec 31, 2023 | -215.44% |
| Sep 30, 2023 | -186.58% |
| Jun 30, 2023 | -138.16% |
| Mar 31, 2023 | -92.07% |
| Dec 31, 2022 | -71.82% |
| Sep 30, 2022 | -53.61% |
| Jun 30, 2022 | -35.29% |
| Mar 31, 2022 | -26.33% |
| Dec 31, 2021 | -27.65% |